Clinical Trials Directory

Trials / Completed

CompletedNCT01081249

Effects of Oxytocin on Behavior and Physiology in a Psychotherapy Setting

Physiologic Correlates of Perceived [Therapist] Empathy and Social-Emotional Process During Psychotherapy: Testing Oxytocin in a Cross-Over Design Pilot Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
18 (actual)
Sponsor
MacDonald, Kai, M.D. · Individual
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Subjects-currently in outpatient mental health care--will participate in 2 psychotherapy sessions, one with oxytocin spray and one with placebo spray. Sessions will be videotaped, and cortisol and heart rate will be measured. We hypothesize that oxytocin will have positive benefits on nonverbal behavior in the therapy session, as well as have positive effects on subjective anxiety, cortisol and heart rate.

Conditions

Interventions

TypeNameDescription
DRUGPlacebo then intranasal oxytocinParticipant received intranasal placebo spray at first psychotherapy session, and received a single dose of 40 IU intranasal oxytocin at the second session.
DRUGIntranasal oxytocin then placeboParticipant received a single dose of 40 IU intranasal oxytocin at the first psychotherapy session, and received a similar dose of intranasal placebo spray at the second session.

Timeline

Start date
2008-12-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2010-03-05
Last updated
2014-10-16
Results posted
2014-10-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01081249. Inclusion in this directory is not an endorsement.